A. Bockisch, L. S. Freudenberg, D. Schmidt, and T. Kuwert,

P. Spect/ct and . Ct, Proven Outcomes in Cancer Imaging, Semin Nucl Med, vol.39, issue.4, pp.276-289

C. Marcus, E. Mena, and R. M. Subramaniam, Brain PET in the Diagnosis of Alzheimer's Disease, Clin Nucl Med, vol.39, issue.10, pp.423-426, 2014.

N. R. Evans, J. M. Tarkin, J. R. Buscombe, H. S. Markus, J. H. Rudd et al., PET Imaging of the Neurovascular Interface in Cerebrovascular Disease, Nat Rev Neurol, vol.13, issue.11, pp.676-688, 2017.

K. E. Mccabe, A. M. Wu, F. C. Van-de-watering, M. Rijpkema, L. Perk et al., Positive Progress in ImmunoPET-Not Just a Coincidence, Cancer Biotherapy & Radiopharmaceuticals, vol.25, issue.3, p.89, 2010.

, Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients, BioMed Research International, vol.2014, pp.1-13

M. Shokeen and C. J. Anderson, Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET), Acc. Chem. Res, vol.42, issue.7, pp.832-841, 2009.

E. Caserta, J. Chea, M. Minnix, D. Viola, S. Vonderfecht et al., Copper 64-Labeled Daratumumab as a PET/CT Imaging Tracer for Multiple Myeloma, Blood, vol.131, issue.7, pp.741-745, 2018.

A. Pfeifer, U. Knigge, J. Mortensen, P. Oturai, A. K. Berthelsen et al., Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study, Journal of Nuclear Medicine, vol.53, issue.8, pp.1207-1215, 2012.

C. B. Johnbeck, U. Knigge, A. Loft, A. K. Berthelsen, J. Mortensen et al., Head-to-Head Comparison of 64 Cu-DOTATATE and 68 Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors, Journal of Nuclear Medicine, vol.58, issue.3, pp.451-457, 2017.

C. Malmberg, R. S. Ripa, C. B. Johnbeck, and U. Knigge,

S. W. Langer, J. Mortensen, P. Oturai, A. Loft, A. M. Hag et al., 2015) 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients, Journal of Nuclear Medicine, vol.56, issue.12, pp.1895-1900

L. M. Lima, D. Esteban-gómez, R. Delgado, C. Platasiglesias, and R. Tripier, Monopicolinate Cyclen and Cyclam Derivatives for Stable Copper(II) Complexation, Inorg. Chem, vol.51, issue.12, pp.6916-6927, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01557438

M. Frindel, N. Camus, A. Rauscher, M. Bourgeois, C. Alliot et al., Radiolabeling of HTE1PA: A New Monopicolinate Cyclam Derivative for Cu-64 Phenotypic Imaging. In Vitro and in Vivo Stability Studies in Mice, Nucl Med Biol, pp.49-57, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01529578

M. Frindel, P. Le-saëc, M. Beyler, A. Navarro, C. Saï-maurel et al., Cyclam Te1pa for 64 Cu PET Imaging. Bioconjugation to Antibody, Radiolabeling and Preclinical Application in Xenografted Colorectal Cancer, vol.7, pp.9272-9283, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01463724

L. Bihan, T. Navarro, A. Le-bris, N. Le-saec, P. Gouard et al., Synthesis of C-Functionalized TE1PA and Comparison with Its Analogues. An Example of Bioconjugation on 9E7.4 MAb for Multiple Myeloma 64Cu-PET Imaging, Org Biomol Chem, vol.16, issue.23, pp.4261-4271, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01804657

N. Fichou, S. Gouard, C. Maurel, J. Barbet, L. Ferrer et al., Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 Is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model, Frontiers in Medicine, vol.2, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01817464

C. Bailly, S. Gouard, M. Lacombe, P. Saëc, B. Chalopin et al., Comparison of Immuno-PET of CD138 and PET Imaging with, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01677118

, CuCl 2 and 18 F-FDG in a Preclinical Syngeneic Model of Multiple Myeloma, Oncotarget, issue.10, p.9

L. A. Bass, M. Wang, M. J. Welch, and C. J. Anderson, , 2000.

, In Vivo Transchelation of Copper-64 from TETA-Octreotide to

, Superoxide Dismutase in Rat Liver, Bioconjug Chem, vol.11, issue.4, pp.527-532

S. C. Ghosh, K. L. Pinkston, H. Robinson, B. R. Harvey, N. Wilganowski et al., Comparison of DOTA and NODAGA as Chelators for (64)CuLabeled Immunoconjugates, Nucl. Med. Biol, vol.42, issue.2, pp.177-183, 2015.

A. E. Karlström, M. Haaparanta-solin, T. J. Grönroos, O. Solin, and A. Orlova, Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA, Contrast Media Mol Imaging, p.8565802, 2017.

N. M. Bartolo, A. M. Sargeson, T. M. Donlevy, and S. V. Smith, Synthesis of a New Cage Ligand, SarAr, and Its Complexation with Selected Transition Metal Ions for Potential Use in Radioimaging, Nature Protocols, vol.1, issue.15, pp.3062-3068, 2001.

C. A. Boswell, X. Sun, W. Niu, G. R. Weisman, E. H. Wong et al., Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes, J. Med. Chem, vol.47, issue.6, pp.1465-1474, 2004.

D. L. Kukis, M. Li, and C. F. Meares, , 1993.

. Antibody-chelate, Conjugates for Binding Copper in the Presence of Competing Metals, Inorg. Chem, vol.32, issue.19, pp.3981-3982

V. Maheshwari, J. L. Dearling, S. T. Treves, and A. B. Packard, Measurement of the Rate of Copper(II) Exchange for 64Cu Complexes of Bifunctional Chelators, Inorganica Chimica Acta, vol.393, pp.318-323, 2012.

P. Moreau, M. Attal, D. Caillot, M. Macro, L. Karlin et al., Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study, J. Clin. Oncol, vol.35, issue.25, pp.2911-2918, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01726512

H. J. Wester, U. Keller, M. Schottelius, A. Beer, K. Philippabbrederis et al., Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging, World Journal of Gastroenterology, vol.5, issue.6, p.221, 2015.

K. Westerlund, H. Honarvar, E. Norrström, J. Strand, B. Mitran et al., Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules, Mol. Pharmaceutics, vol.13, issue.5, pp.1668-1678, 2016.

C. Qin, H. Liu, K. Chen, X. Hu, X. Ma et al., Theranostics of Malignant Melanoma with 64CuCl2, Journal of Nuclear Medicine, vol.55, issue.5, pp.812-817, 2014.

J. Radl, J. W. Croese, C. Zurcher, M. H. Van-den-enden-vieveen, and A. M. De-leeuw, Animal Model of Human Disease, 1988.

M. Myeloma, The American Journal of Pathology, vol.132, issue.3, pp.593-597